Literature DB >> 19369364

The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.

Diana Spicarova1, Jiri Palecek.   

Abstract

Transient receptor potential vanilloid (TRPV1) receptors are abundant in a subpopulation of primary sensory neurons that convey nociceptive information from the periphery to the spinal cord dorsal horn. The TRPV1 receptors are expressed on both the peripheral and central branches of these dorsal root ganglion (DRG) neurons and can be activated by capsaicin, heat, low pH, and also by recently described endogenous lipids. Using patch-clamp recordings from superficial dorsal horn (DH) neurons in acute spinal cord slices, the effect of application of the endogenous TRPV1 agonist N-oleoyldopamine (OLDA) on the frequency of miniature excitatory postsynaptic currents (mEPSCs) was evaluated. A high concentration OLDA (10 microM) solution was needed to increase the mEPSC frequency, whereas low concentration OLDA (0.2 microM) did not evoke any change under control conditions. The increase was blocked by the TRPV1 antagonists SB366791 or BCTC. Application of a low concentration of OLDA evoked an increase in mEPSC frequency after activation of protein kinase C by phorbol ester (PMA) and bradykinin or in slices from animals with peripheral inflammation. Increasing the bath temperature from 24 to 34 degrees C enhanced the basal mEPSC frequency, but the magnitude of changes in the mEPSC frequency induced by OLDA administration was similar at both temperatures. Our results suggest that presumed endogenous agonists of TRPV1 receptors, like OLDA, could have a considerable impact on synaptic transmission in the spinal cord, especially when TRPV1 receptors are sensitized. Spinal TRPV1 receptors could play a pivotal role in modulation of nociceptive signaling in inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369364     DOI: 10.1152/jn.00024.2009

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  24 in total

1.  Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation.

Authors:  Carl Weitlauf; Nicholas J Ward; Wendi S Lambert; Tatiana N Sidorova; Karen W Ho; Rebecca M Sappington; David J Calkins
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine.

Authors:  Vladimir Nerandzic; Petra Mrozkova; Pavel Adamek; Diana Spicarova; Istvan Nagy; Jiri Palecek
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

Review 3.  Sensory TRP channels: the key transducers of nociception and pain.

Authors:  Aaron D Mickle; Andrew J Shepherd; Durga P Mohapatra
Journal:  Prog Mol Biol Transl Sci       Date:  2015-02-12       Impact factor: 3.622

Review 4.  Unravelling the mystery of capsaicin: a tool to understand and treat pain.

Authors:  Jessica O'Neill; Christina Brock; Anne Estrup Olesen; Trine Andresen; Matias Nilsson; Anthony H Dickenson
Journal:  Pharmacol Rev       Date:  2012-10       Impact factor: 25.468

5.  Elevation of Transient Receptor Potential Vanilloid 1 Function in the Lateral Habenula Mediates Aversive Behaviors in Alcohol-withdrawn Rats.

Authors:  Danielle M Gregor; Wanhong Zuo; Rao Fu; Alex Bekker; Jiang-Hong Ye
Journal:  Anesthesiology       Date:  2019-04       Impact factor: 7.892

Review 6.  Regulation of Pain and Itch by TRP Channels.

Authors:  Carlene Moore; Rupali Gupta; Sven-Eric Jordt; Yong Chen; Wolfgang B Liedtke
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

7.  Tumor necrosis factor alpha sensitizes spinal cord TRPV1 receptors to the endogenous agonist N-oleoyldopamine.

Authors:  Diana Spicarova; Jiri Palecek
Journal:  J Neuroinflammation       Date:  2010-08-26       Impact factor: 8.322

8.  Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.

Authors:  Yasunori Haranishi; Koji Hara; Tadanori Terada
Journal:  Pharmacol Rep       Date:  2021-03-30       Impact factor: 3.024

9.  Suppression of TRPV1/TRPM8/P2Y Nociceptors by Withametelin via Downregulating MAPK Signaling in Mouse Model of Vincristine-Induced Neuropathic Pain.

Authors:  Adnan Khan; Bushra Shal; Ashraf Ullah Khan; Rahim Ullah; Muhammad Waleed Baig; Ihsan Ul Haq; Eun Kyoung Seo; Salman Khan
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

10.  TRPV1 and TRPV4 play pivotal roles in delayed onset muscle soreness.

Authors:  Hiroki Ota; Kimiaki Katanosaka; Shiori Murase; Makiko Kashio; Makoto Tominaga; Kazue Mizumura
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.